Shattuck Labs, Inc. (STTK)
5.655
-0.20
(-3.50%)
USD |
NASDAQ |
Oct 07, 16:00
5.65
0.00 (0.00%)
After-Hours: 20:00
Shattuck Labs Net Income (Quarterly) : -15.15M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.15M |
| March 31, 2026 | -14.77M |
| December 31, 2025 | -12.59M |
| September 30, 2025 | -10.06M |
| June 30, 2025 | -12.46M |
| March 31, 2025 | -13.70M |
| December 31, 2024 | -18.68M |
| September 30, 2024 | -16.68M |
| June 30, 2024 | -21.55M |
| March 31, 2024 | -18.50M |
| December 31, 2023 | -17.69M |
| September 30, 2023 | -27.54M |
| June 30, 2023 | -21.35M |
| March 31, 2023 | -20.72M |
| Date | Value |
|---|---|
| December 31, 2022 | -25.41M |
| September 30, 2022 | -24.64M |
| June 30, 2022 | -27.37M |
| March 31, 2022 | -24.53M |
| December 31, 2021 | 7.847M |
| September 30, 2021 | -17.41M |
| June 30, 2021 | -23.60M |
| March 31, 2021 | -11.81M |
| December 31, 2020 | -12.01M |
| September 30, 2020 | -11.83M |
| June 30, 2020 | -6.208M |
| March 31, 2020 | -6.554M |
| December 31, 2019 | -7.369M |
| September 30, 2019 | -7.279M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
| Biogen, Inc. | 97.50M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 15.15M |
| EPS Diluted (Quarterly) | -0.1168 |
| Enterprise Value | 363.98M |
| Earnings Yield | -9.00% |
| Normalized Earnings Yield | -8.990 |